SCHEMBL20004441

SCHEMBL20004441

CCc1ccc(Oc2ccc(N(C)CCO)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 4/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ LTA4H P09960 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ CYP2C19 P33261 1/20 0.37
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ MMP2 P08253 1/20 0.35
▸ MMP9 P14780 1/20 0.35
▸ KDM4C Q9H3R0 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ S1PR1 P21453 2/20 0.34
▸ S1PR3 Q99500 1/20 0.34
▸ SLC9A5 Q14940 1/20 0.34
▸ RXRA P19793 1/20 0.34
▸ RXRB P28702 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13849628 0.89 L3MBTL1 (0.45) SMN1; SMN2L3MBTL1TSHRSLC9A5
SCHEMBL22537487 0.83 L3MBTL1 (0.51) SMN1; SMN2L3MBTL1LTA4HTSHRHSD17B10
SCHEMBL22537499 0.83 MMP13 (0.44) SMN1; SMN2L3MBTL1TSHRMMP2MMP9
SCHEMBL20005167 0.79 MAPT (0.41) SMN1; SMN2L3MBTL1TSHRMEN1KMT2A
SCHEMBL20004348 0.79 L3MBTL1 (0.48) SMN1; SMN2L3MBTL1MEN1KMT2AMMP2
SCHEMBL15466179 0.77 RPS6KA2 (0.45) SMN1; SMN2L3MBTL1TSHRMEN1KMT2A
1,4-Butanediol SCHEMBL4599328 0.76 LTA4H (0.47) SMN1; SMN2LTA4HCYP2C19NPC1RAB9A
SCHEMBL11343713 0.76 ALDH1A1 (0.54) L3MBTL1LTA4HTSHRMEN1KMT2A
SCHEMBL8925998 0.75 SMN1; SMN2 (0.48) SMN1; SMN2LTA4HCYP2C19NPC1RAB9A
SCHEMBL475215 0.75 SMN1; SMN2 (0.48) SMN1; SMN2LTA4HCYP2C19NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018055316-A1 COMPOUNDS FOR USING IN IMAGING AND PARTICULARLY FOR THE DIAGNOSIS OF NEURODEGENERATIVE DISEASES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2018-03-29 — — WO disclosed
Send feedback